Chris Glasper

Chris Glasper is a seasoned Healthcare Equity Research Analyst at Singer Capital Markets, a position held since October 2012, where involvement includes covering approximately 15 UK listed companies and contributing to the IPOs of CareTech and Synexus. Prior experience encompasses roles as Partner in Equity Research at N+1 Brewin and Director of Equity Research at Brewin Dolphin, where Chris also started as an Analyst. An academic background includes a BA Hons in Economics & Politics from the University of York and education at the Royal Grammar School Newcastle.